资讯

FDA’s New Drug Approval AI Is Generating Fake Studies: Report
But three of those FDA employees told CNN that Elsa just makes up nonexistent studies, something commonly referred to in AI ...
FDA’s artificial intelligence is supposed to revolutionize drug approvals. It’s making ...
Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is ...
The Well News on MSN7 小时Opinion
Released FDA Files Show Flawed Drug Approval Process
For decades, the Food and Drug Administration has been notoriously tight-lipped about why it rejects drugs. It has remained ...
US FDA extends review of GSK's blood cancer drug
The U.S. Food and Drug Administration has extended its review of GSK's blood cancer drug, Blenrep, as a combination treatment ...
Omaha mom expects new FDA decision on son's 'lifesaving' drug soon
The Food and Drug Administration is reconsidering its decision not to approve a drug that an Omaha mom says is saving her son ...
FDA appoints George Tidmarsh as top drug regulator
The U.S. Food and Drug Administration said on Monday it has appointed George Tidmarsh, a seasoned biotech executive and ...
FDA Names Biotech Veteran George Tidmarsh To Lead Drug Evaluation Division
George Tidmarsh appointed to lead FDA drug review division amid staffing cuts and scrutiny over accelerated approvals and ...
FDA Suspends Muscular Dystrophy Drug After 3 Patient Deaths
The U.S. Food and Drug Administration ( FDA) has placed an immediate clinical hold on Sarepta Therapeutics' investigational ...
Fierce Biotech1 天
Replimune's shares crater as FDA rejects melanoma drug
The FDA has rejected Replimune’s request for approval of RP1, adding the melanoma drug candidate to the list of assets to ...
Becker's Hospital Review2 天
Cuts to NIH, FDA could slash drug approvals: 5 notes
An analysis from the Congressional Budget Office warns that cuts to the National Institutes of Health and FDA drug reviews could significantly reduce the number of new medications reaching the U.S.
Daily Graphic20 小时
FDA Ghana’s disclaimer on purported approval of COA 72 for clinical trials as an anti-HIV ...
The Food and Drugs Authority (FDA) has taken note of a publication on the front page of the Daily Graphic dated Wednesday, ...
Managed Healthcare Executive1 天
FDA Delays Approval of Replimune’s Melanoma Therapy Despite Promising Trial Results
Replimune's RP1 treatment for advanced melanoma faces FDA rejection due to trial design issues, despite promising results ...